Connect your AI

McKesson MCK North American Pharmaceutical — Payments for Restructuring

Other segment segments

Medical-Surgical Solutions

$3M-93.8%

Prescription Technology Solutions

$1M0.0%

Oncology & Multispecialty

$0—

Similar metrics at other companies

XPO

XPONorth American Intermodal Operation — Payments for Restructuring

$0-100%

ESABAmericas: — Payments for Restructuring

$7.11M—

TAPAmericas — Payments for Restructuring

-$12.8M-25,500%

MANAmericas — Payments For Restructuring

$3.4M+30.8%

MSA

MSAAmericas segment — Payments for Restructuring

$400K+300%

INGMNorth America — Restructuring Charges

$5.32M+463%

Other financials

Income statement

Revenue$96.3B+6.0%

Gross profit$4.0B+11.1%

Operating income$2.2B+35.1%

Net income$1.7B+33.5%

EPS (diluted)$13.65+37.6%

Balance sheet

Cash & equivalents$4.0B-33.3%

Total debt$2.3B-74.2%

Total equity-$2.2B-4.7%

Total assets$82.3B+9.6%

Cash flow

Operating cash flow$3.4B-55.8%

CapEx$111.0M-34.3%

Free cash flow$3.3B-56.3%

Valuation

Market cap$89.75B-0.4%

Enterprise value$88.05B-5.3%

P/E18.9×-8.5×

P/S0.2×0.0×

Profitability

Gross margin3.6%-0.1pp

Operating margin1.5%+0.3pp

Net margin1.2%+0.3pp

FCF margin1.4%-0.1pp

Returns & leverage

Return on equity36%—

Debt / equity2×—

Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRestructuring.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's north american pharmaceutical — payments for restructuring.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is McKesson's north american pharmaceutical — payments for restructuring?: McKesson (MCK) reported north american pharmaceutical — payments for restructuring of $1M in Q1 2026.
How has McKesson's north american pharmaceutical — payments for restructuring changed year-over-year?: McKesson's north american pharmaceutical — payments for restructuring decreased by 50.0% year-over-year, from $2M to $1M.
What does north american pharmaceutical — payments for restructuring mean?: Actual cash outflows related to the implementation of restructuring programs within the North American pharmaceutical segment. This includes costs for severance, facility closures, and other organizational realignment activities.